Financial/Business

2024 Orthopedic Device M&A Roundup (Updated 11/18)

A quick reference of all the mergers and acquisitions that took place within the orthopedic design and technology space (suppliers and OEMs) in 2024.

The orthopedic device landscape is undergoing a seismic shift, fueled by a surge in mergers and acquisitions. Specialized players are being absorbed by industry leaders, driven by a desire for new technologies, expanded markets, and enhanced capabilities.

To navigate this transformative year, we’ve launched this dedicated resource – your essential guide to every major orthopedic design and technology M&A deal. Stay ahead of the curve, track key partnerships, and understand the industry’s reshaping with concise updates and insightful analysis. Return to this page and prepare to witness the future of the orthopedic device industry unfold, transaction by transformative transaction.

Anika Therapeutics—Phoenix Bio Inc.

The company has sold its Arthrosurface business for $10 million to Phoenix Brio Incorporated and announced its intent to divest its sports medicine franchise (Parcus Medical).
Date of Announcement: October 31, 2024
Value: $10 million
More info

RTI Surgical—Collagen Solutions

RTI will gain engineered medical-grade collagen and xenograft tissue with applications in sports medicine, orthopedics, and cardiac.
Date of Announcement: October 7, 2024
Value: Not disclosed
More info

Bioventus—Accelmed

Bioventus Inc. signed a definitive agreement to sell its Bioness Advanced Rehabilitation business to Accelmed Partners.
Date of Announcement: October 2, 2024
Value: $45 million
More info

Stryker—Vertos Medical

Vertos is a developer of interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis.
Date of Announcement: October 1, 2024
Value: Not disclosed
More info

Leap Distributors—Leap Surgical & DUB Enterprises

Dallas-based Leap Surgical supplies products and services to the medical community, helping its clients stay up to updated on the latest procedural solutions. Dub Enterprises supplies multiple product lines and services to the medical device industry.
Date of Announcement: September 19, 2024
Value: Not disclosed
More info

Bone Health Technologies—Wellen

The acquisition of Wellen advances Bone Health Technologies’ mission of a comprehensive, one-stop, multi-modal bone health solution.
Date of Announcement: July 26, 2024
Value: Not disclosed

Clariance—SpineVision

The merged Clariance SpineVision company now offers a wide product range including Erisma-LP, Hexanium, Flex+2, and a pipeline driven by a shared vision for advancing enabling technologies.
Date of Announcement: June 12, 2024
Value: Not disclosed
More info

Stryker—Artelon

Privately-held Artelon will add differentiated synthetic technology designed to enhance biological and mechanical ligament and tendon reconstruction to Stryker’s lineup of foot/ankle and sports medicine offerings.
Date of Announcement: June 3, 2024 (closed July 15, 2024)
Value: Not disclosed
More info

HealthpointCapital—SteriCUBE Holdings Inc.

HealthpointCapital, a private equity firm, acquired a majority stake in SteriCUBE Holdings, Inc. and appointed Chris Whitmore CEO.
Date of Announcement: April 10, 2024
Value: Undisclosed
More info

Zeda Health—The Orthopaedic Implant Company (OIC)

The acquisition of the high-value trauma implant maker fortifies Zeda’s position in the global orthopedic industry as a firm developing and using leading design and manufacturing technologies.
Date of Announcement: February 13, 2024
Value: Undisclosed
More info

Smith+Nephew—CartiHeal

Smith+Nephew, the global medical technology company, acquired CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee.
Date of Announcement: January 10, 2024
Value: $180 million on completion, with up to a further $150 million contingent on future financial performance
More info

OrthoPediatrics—Boston Orthotics & Prosthetics

OrthoPediatrics acquired Boston Orthotics & Prosthetics, a company that has focused on pediatric orthotic management for more than 50 years.
Date of Announcement: January 8, 2024
Value: Undisclosed
More info

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters